Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Acura Pharma Cmn (ACUR)

Acura Pharma Cmn (ACUR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 5,627
  • Shares Outstanding, K 21,643
  • Annual Sales, $ 410 K
  • Annual Income, $ -3,840 K
  • 60-Month Beta 1.40
  • Price/Sales 1.60
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 12/31/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2000 +62.75%
on 12/31/19
0.4679 -30.43%
on 01/14/20
+0.0655 (+25.19%)
since 12/23/19
3-Month
0.2000 +62.75%
on 12/31/19
0.6300 -48.33%
on 11/08/19
-0.0145 (-4.26%)
since 10/21/19
52-Week
0.1301 +150.19%
on 06/19/19
0.6300 -48.33%
on 11/08/19
+0.1825 (+127.62%)
since 01/23/19

Most Recent Stories

More News
Acura Pharmaceuticals Provides an Update on the Development of LTX-03

Acura Pharmaceuticals, Inc. (OTC Pink: ACUR), today provided an update on its development of LTX-03 (Hydrocodone Bitartrate and Acetaminophen) Tablets using Acura's LIMITx(TM) technology intended to mitigate...

ACUR : 0.3255 (+25.19%)
Acura Pharmaceuticals Announces First Quarter 2019 Financial Results

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and product candidates intended to mitigate the risk of outcomes...

ACUR : 0.3255 (+25.19%)
Acura Pharmaceuticals Announces Fourth Quarter 2018 and Full Year 2018 Financial Results

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and product candidates intended to mitigate the risk of outcomes...

ACUR : 0.3255 (+25.19%)
Acura Pharmaceuticals Engages Catalent Pharma Solutions to Advance Development of LTX-03

Acura Pharmaceuticals, Inc. (OTC Pink: ACUR), today announced that it has engaged Catalent Pharma Solutions, LLC ("Catalent") to initiate manufacturing scale-up of LTX-03 (Hydrocodone Bitartrate and Acetaminophen)...

ACUR : 0.3255 (+25.19%)
Acura Pharmaceuticals Licenses LIMITx(TM) LTX-03

Agreement Provides For Completion of Development and Commercialization

ACUR : 0.3255 (+25.19%)
OTC Markets Group Announces Lists of Compliance Downgrades and Caveat Emptor Designations for the Month of May

ABPA : 0.0001 (unch)
ACUR : 0.3255 (+25.19%)
AENG : 0.0001 (-96.43%)
ARME : 0.0020 (+53.85%)
ASFT : 1.3000 (unch)
AVTO : 0.0050 (+11.11%)
BAYN : 0.0147 (unch)
BGII : 0.0040 (unch)
BIIO : 0.0124 (-63.31%)
BOXS : 0.0042 (unch)
BRBI : 0.0001 (unch)
CASG : 0.0001 (unch)
CEFB : 0.0195 (unch)
CELX : 0.0021 (unch)
CORX : 0.0210 (unch)
CPEU : 0.0001 (unch)
DREM : 0.1450 (+129.43%)
DTHR : 0.0300 (unch)
ENCR : 0.0710 (+1.43%)
FCHS : 0.1601 (-11.06%)
FRLI : 0.2100 (+10.53%)
FVVSF : 0.0257 (-27.61%)
GOPH : 0.0490 (-9.26%)
GXXM : 0.0001 (unch)
IMGL : 0.0100 (-50.00%)
ISBG : 0.0012 (+50.00%)
LOGQ : 0.1787 (+47.56%)
MCVT : 0.5400 (-10.00%)
MJNE : 0.2002 (-14.70%)
NXNN : 1.6600 (-13.54%)
ORMNF : 0.0750 (-3.10%)
REBL : 2.5900 (unch)
SLSDF : 0.0246 (-14.29%)
SNPW : 0.0019 (unch)
TMIAF : 0.0950 (+21.48%)
UCSO : 0.0071 (unch)
VCSY : 0.0063 (-4.55%)
VIBI : 0.0001 (unch)
VYEY : 0.4000 (+166.67%)
ZENO : 0.0365 (-8.75%)
OTCM : 34.4500 (-0.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ACUR with:

Key Turning Points

2nd Resistance Point 0.4247
1st Resistance Point 0.3751
Last Price 0.3255
1st Support Level 0.3007
2nd Support Level 0.2759

See More

52-Week High 0.6300
Fibonacci 61.8% 0.4390
Fibonacci 50% 0.3801
Last Price 0.3255
Fibonacci 38.2% 0.3211
52-Week Low 0.1301

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar